This study examined the efficacy of a technique of administration of lignocaine 2% (with 1:200,000 adrenaline) to the nose, pharynx and larynx. A simple device constructed from a 22 gauge Optiva® cannula attached to a medical oxygen supply via green "bubble" tubing and the barrel of a 3 ml syringe, similar to that described by Mackenzie 1 , was used to administer aerosolized lignocaine initially via the nose and subsequently via a nasopharyngeal airway. Ten unsedated, unpremedicated volunteers were intubated. The mean time from the start of the administration of lignocaine to confirmation of placement of the endotracheal tube was 12 minutes (range 8 to 19 minutes). Intubating conditions were good and the procedure was well tolerated in all subjects. The mean dose of lignocaine was 4.8 mg.kg -1 (range 2.7 to 6.9 mg.kg -1 ) and plasma concentrations were well below toxic levels (highest concentration 3.12 mg.l -1 ). There was good haemodynamic stability and no episode of oxyhaemoglobin desaturation.
Endotracheal intubation of the awake patient is an important skill for the anaesthetist to possess. Awake fibreoptic intubation is indicated in a range of circumstances. Under broad headings they include the predicted difficult intubation (particularly in the presence of a potentially difficult airway or the risk of aspiration), potentially unstable cervical spine, high aspiration risk and patients in whom it is particularly desirable to avoid the adverse cardiovascular responses caused by direct laryngoscopy [2] [3] [4] [5] .
Since 1967, when the fibreoptic bronchoscope was first described to assist awake nasal intubation 6 , it has become the "gold standard" technique for difficult endotracheal intubation 2 . However, achieving adequate anaesthesia of the nose and upper airways of these patients requires both a skilled operator and adequate time to perform the procedure 2, 3 . It is well known that the more conventional methods of administration of local anaesthetic and sedation in these patients are not without problems. Poor tolerance of the relatively invasive local anaesthetic technique frequently necessitates the use of sedative drugs, with the inherent risks of loss of a patent airway, aspiration or the patient becoming uncooperative 2, 3, 7 . The techniques also often require doses in excess of the "maximum recommended safe dose" of the drugs used 8 to achieve adequate local anaesthesia for awake nasal intubation, though plasma lignocaine concentrations have been shown on several occasions to remain within "safe" limits despite the high doses administered 9, 10 .
The aim of this study was to examine a technique of administration of local anaesthetic to the nose, pharynx and larynx. The technique was intended to be simple and quick to perform, well tolerated by the subjects and less invasive than previously described methods. We planned to investigate the physiological changes associated with this technique, the amount of lignocaine required (and plasma levels after administration), the time taken to perform the procedure and "patient acceptability" in a group of cooperative, unsedated volunteers.
MATERIALS AND METHODS
Prior to beginning the study, ethics committee approval was sought to recruit volunteers from within the Department of Anaesthesia and Resuscitation and for the performance of the procedure. This was granted in accordance with the protocols of the Queen Elizabeth Hospital.
Ten healthy, well-informed volunteers (anaesthetic registrars and consultants) consented to undergo awake fibreoptic intubation using this technique. Inclusion, exclusion and withdrawal criteria are listed in Table 1 . All subjects were fasted for a minimum of six hours prior to the procedure. No premedication was used.
For the purpose of administration of the local anaesthetic, we used a simple construction of an Optiva (Johnson and Johnson, Aprilia, Italy) 22 gauge cannula attached to a medical oxygen supply via green "bubble" tubing and the barrel of a 3 ml syringe ( Figure 1 ). This is almost identical to the device constructed by Mackenzie to assist his technique of awake intubation 1 . With a gas flow of 1 to 2 l.min -1 , injection of lignocaine via the side-port resulted in a fine aerosol spray arising from the cannula tip.
The procedure was performed in the Recovery Department of the Queen Elizabeth Hospital in the presence of a consultant anaesthetist and registrar. Subjects were monitored throughout the 30-minute study period with non-invasive blood pressure measurements (every two minutes) and continuous pulse oximetry. A 20 gauge IV cannula was placed in the subjects' antecubital fossa for venous blood sampling and emergency access. The maximum total dose of lignocaine to be available for use during the procedure was limited to 7 mg.kg -1 of 2% lignocaine with adrenaline (1:200,000) in accordance with the study protocol. This amount was drawn up into 10 ml syringes.
Each subject was positioned sitting erect on a standard hospital trolley. Each subject nominated the clearer nostril to use for the procedure. Lignocaine 2% 5 to 10 ml with adrenaline was then administered in increments of 0.5 ml to the nostril of choice using the device described. A 6.5 mm nasopharyngeal airway (Argyle Glide-Tex, Sherwood Medical Co, St Louis, U.S.A.) lubricated with 1 ml of 2% lignocaine gel was then passed into the nasopharynx. Where the subjects found the insertion of the nasopharyngeal airway uncomfortable it was withdrawn and additional lignocaine with adrenaline was used for the nose. A further 5 to 10 ml of 2% lignocaine with adrenaline was administered in 0.5 ml increments via the nasopharyngeal airway, timed with slow, deep inspiration. Anaesthesia of the vocal cords was taken to be indicated by a change in voice.
Following this, the nasopharyngeal airway was removed and a lubricated 6.0 mm Portex Blue Line Ivory endotracheal tube (Portex Ltd., Hythe, Kent, U.K.) was inserted through that nostril into the oropharynx. An Olympus LF1 fibreoptic bronchoscope (Olympus Optical Co. Ltd., Tokyo, Japan), fitted with a camera, was passed through the endotracheal tube and manoeuvred into the trachea. Once the tip of the fibreoptic bronchoscope was past the vocal cords, a further 2 ml of lignocaine with adrenaline was instilled into the trachea via the side port of the scope. The endotracheal tube was then gently advanced over the bronchoscope into the trachea and the cuff inflated. Its position in the trachea was confirmed by direct vision and the fibreoptic bronchoscope was then completely withdrawn. After a short interval (between 30 and 60 seconds) the endotracheal tube cuff was deflated and the subject extubated.
Blood pressure, pulse oximetry and heart rate were recorded for a 30-minute period. Time zero (t 0 ) was the time of the initial administration of lignocaine. The length of time to confirmation of placement of the endotracheal tube in the trachea was noted (t i ).
The total dose of lignocaine with adrenaline used was noted. Venous blood samples were taken for measurement of plasma lignocaine concentration at 10, 20 and 30 minutes (t 10 , t 20 lignocaine concentrations have been previously found to occur at 15 to 30 minutes after the start of administration to nose and trachea 9, 10 . The plasma lignocaine concentration was measured using high-performance liquid chromatography 11 .
On completion of the procedure, the subjects were asked to "grade" the degree of discomfort of the whole procedure on a scale of 0 to 4 ( Table 2 ). Any additional comments were documented, along with a subjective rating by the operator of the degree of difficulty of each intubation.
RESULTS
Ten subjects were studied (seven male and three female). The mean age was 36 years (range 26 to 61) and the mean weight was 83 kg (range 65 to 115).
Fibreoptic intubation of the trachea was possible in all 10 subjects at the first attempt once adequate anaesthesia of the nose and airways had been achieved. The mean time to confirmation of placement of the endotracheal tube in the trachea was 12 minutes (range 8 to 19) and the mean dose of lignocaine (with adrenaline) used was 4.8 mg.kg -1 (range 2.7 to 6.9). The subjects' individual discomfort scores and time to intubation are combined in Table 3 .
Due to a problem with storage of the blood samples, it was only possible to measure the whole blood levels of lignocaine rather than plasma levels on some of the samples. On these samples, the plasma lignocaine level was derived from the measured blood level by using a correction factor of 1.3, based on the plasma to whole blood concentration ratio [12] [13] [14] [15] . The measured and derived plasma levels are shown in Table 4 , with the derived values marked with an asterisk. Subject 5 had the highest recorded plasma lignocaine level (3.12 mg.l -1 ), having been given the largest dose of lignocaine. All other plasma levels were substantially lower. None of the subjects reported or were observed to demonstrate any features of local anaesthetic toxicity. The generally accepted potentially toxic plasma lignocaine level 16 is >5 mg.l -1 .
There were no observed episodes of oxyhaemoglobin desaturation during the study. The lowest recorded pulse oximeter reading was 95%.
The percentage increases from baseline (t 0 ) of the heart rate and mean arterial blood pressure were calculated. The highest recorded percentage increases are shown in Tables 5 and 6 , along with the time relative to t i at which these changes occurred. There was a large variation between the subjects in the maximum percentage increases in heart rate and mean arterial blood pressure and the times at which these increases occurred. The causes of these variations in HR and MAP were presumably multifactorial and included the initial rapid absorption of adrenaline, the volunteers' initial anxiety and the subsequent relief once the intubation had been completed! One of the subjects reported a discomfort score of 3, the rest all reporting scores of 1 or 2. Eight subjects reported a sensation of pressure at "the back of the nose" when the nasopharyngeal airway and then the endotracheal tube were passed into the nasopharynx. The two subjects who did not report this sensation the endotracheal tube towards the back of the nasal passage. Once intubated, all of the subjects were able to breathe easily (at rest) through the endotracheal tube.
From the point of view of the operators, good intubating conditions were provided in all of the subjects. The only difficulties encountered were in passing the fibreoptic bronchoscope through the endotracheal tube in those subjects in whom narrowing of the endotracheal tube was observed. There was no episode of epistaxis.
DISCUSSION
Previously described methods have used a combination of techniques of regional anaesthesia. Premedication with antisialogogues and sedative drugs including opiates, benzodiazepines and major tranquillizers is common 3, 7, [17] [18] [19] [20] . The addition of some form of intravenous sedation during the procedure is almost uniformly seen [2] [3] [4] 7, 9, [17] [18] [19] [20] [21] . Methods using a combination of nebulized lignocaine, topical lignocaine and/or cocaine and either cricothyroid puncture or nerve blocks tend to be most frequently used [2] [3] [4] 7, 10, [17] [18] [19] [20] [21] . Many still use cocaine 7, 19, 20 for both ease of application and its vasoconstrictive effect on the nasal mucosa.
There are a number of concerns regarding these techniques. First, they are relatively complex and thus require experienced operators and adequate time to perform to a high standard 2,3,21 . Second, the anaesthetic procedure and passage of the endotracheal tube are not always well tolerated by subjects, necessitating the administration of sedative drugs to improve comfort. This adds another element of risk to the procedure, with the potential of loss of a patent airway, aspiration or lack of cooperation 2,3,7 . Third, the choice of either cocaine or benzocaine for nasal anaesthesia has been shown to be associated with coronary artery spasm and hypertension in "at risk" patients 22, 23 or methaemoglobinaemia 24 respectively.
Additionally, the administration of lignocaine via nebulizer is associated with a variable amount of wastage 25 , such that the administered dose of nebulized lignocaine may have little resemblance to the dose absorbed. As a consequence, techniques that use nebulized lignocaine frequently require the administration of high doses 9,10,18 , though they have generally demonstrated safe plasma lignocaine concentrations 9, 12, 18 .
To avoid these potential problems, the ideal anaesthetic technique would be easy to perform, using equipment easily found in the anaesthetic workroom. A local anaesthetic drug with minimal side-effects would be the agent of choice. It should be effective enough (at non-toxic doses) for the laryngoscopy and intubation to be well tolerated without the need for sedation. It should provide good conditions for performance of the procedure. An accurate way of measuring (and limiting) the administered dose of local anaesthetic would be desirable.
The procedure described here has many of these advantages. No complicated or expensive equipment is required, with all items used readily found in the anaesthetic workroom. It is simply performed and easily reproducible. Five of the 10 intubations were performed by a consultant anaesthetist and the other five by a junior registrar. It has the advantage of achieving good intubating conditions more rapidly than previously described methods, with a mean time to intubation of 12 minutes compared with times ranging from 16 to 28 minutes in other studies 9, 10 . No episode of epistaxis was seen. It was well tolerated without the need for sedation.
The use of lignocaine with adrenaline in this way avoids the need for cocaine and the potential problems associated with it, while providing effective anaesthesia and vasoconstriction. The technique has displayed cardiovascular stability comparable with other methods 10, [17] [18] [19] 21 . This method of administration allows more accurate measurement of the dose of lignocaine administered. The plasma lignocaine levels were well below toxic levels, even in the one subject who had the maximum permitted dose of lignocaine. It has been suggested that the fact that no antisialogogue was given might work to dilute the nebulized lignocaine, and that the low plasma lignocaine level might also be related to loss of lignocaine by swallowing or with patient exhalation. The cardiovascular changes that were seen might relate to several factors. The degree of anxiety of the subject, discomfort from the procedure and absorption of adrenaline from the nebulized anaesthetic would all serve to raise the mean arterial pressure and heart rate to some extent. The subsequent relief of the subject upon intubation, withdrawal of the stimulus (that is, the endotracheal tube) and the systemic effect of lignocaine might all serve to lower the mean arterial pressure upon completion of the procedure.
Obviously we did not use unbiased volunteers. The technique was new and had not been used on patients or volunteers (other than the authors) prior to the study. The authors believed it would be unsuitable for use on volunteers less well-informed than those used in the study. The subjects used had the advantage (and potential disadvantage) of greater insight into the technique than most volunteers for medical research. This would create bias in the subjective rating of the degree of discomfort and potentially reduce the need for sedation and the mean time to intubation.
CONCLUSION
We have suggested that this technique is of particular use in anaesthetizing the nose and airways for awake intubation in well-informed, cooperative individuals. The technique is quick and easy to learn and does not require sedation or complicated equipment. Tolerance of the procedure is good and cardiovascular stability is comparable to that previously described. The dose of lignocaine administered can be reliably measured to ensure safety with respect to toxicity.
The method described has become the most frequently used for topical anaesthesia of the nose and upper airways at the Queen Elizabeth Hospital for the above reasons. Several other institutions in South Australia and the Northern Territory are also using the technique on a regular basis. It has been considered for the training of registrars on both patients and volunteers. With the adoption of this particular technique into our practice, it will be possible to report a larger series in the future.
